James Mond
Overview
James Mond received an average of $881K in total compensation, including $325K in salary, at ADMA Biologics from 2012 to 2021.
2021ADMA BiologicsFormer Executive Vice President, Chief Scientific Officer and Chief Medical Officer
2020ADMA BiologicsExecutive Vice President, Chief Scientific Officer and Chief Medical Officer
2019ADMA BiologicsExecutive Vice President, Chief Scientific Officer and Chief Medical Officer
2018ADMA BiologicsExecutive Vice President, Chief Scientific Officer and Chief Medical Officer
2017ADMA BiologicsExecutive Vice President, Chief Scientific Officer and Chief Medical Officer
2016ADMA BiologicsExecutive Vice President, Chief Scientific Officer and Chief Medical Officer
2015ADMA BiologicsChief Scientific Officer and Chief Medical Officer
2014ADMA BiologicsChief Scientific Officer and Chief Medical Officer
2013ADMA BiologicsChief Scientific and Medical Officer
2012ADMA BiologicsChief Scientific and Medical Officer
Source: SEC filings on April 28, 2022, April 7, 2021, April 29, 2020, April 24, 2019, April 27, 2018, April 29, 2016, and April 29, 2014.
Related executives
We found two more executives who work or worked at ADMA Biologics.
News
ADMA Biologics CEO Adam Grossman's 2021 pay jumps 122% to $4.4M
April 28, 2022
ADMA Biologics CEO Adam Grossman's 2020 pay rises 15% to $2M
April 7, 2021
ADMA Biologics CEO Adam Grossman's 2019 pay rises 10% to $1.7M
April 29, 2020
ADMA Biologics CEO Adam Grossman's 2018 pay falls 42% to $1.6M
April 24, 2019